Wedbush Raises PT On AET To $42

Wedbush has raised its price target on Aetna Inc. AET from $41 to $42 based upon belief that utilization trends will remain moderate in 1Q11. Wedbush also maintains its Neutral rating on the stock. Wedbush writes, in the report, “We believe the increasing clarity on the impact of healthcare reform and the benefit of credibility adjustments will lead to a multiple expansion in the multi-line group from 9.8x to the 11-13x historical trading range.” AET closed yesterday at $37.28.